How does fulvestrant affect oestrogen receptor protein levels?

Fulvestrant downregulates oestrogen receptor protein levels, significantly reducing them versus placebo in ER-positive primary breast tumours in postmenopausal women, with 500 mg producing greater downregulation than 250 mg in the postmenopausal neoadjuvant setting.